Robaxin and Bundle branch block right - a phase IV clinical study of FDA data

Summary:

Bundle branch block right is reported as a side effect among people who take Robaxin (methocarbamol), especially for people who are female, 40-49 old, also take Vicodin, and have Bone disorder.

The phase IV clinical study analyzes which people have Bundle branch block right when taking Robaxin. It is created by eHealthMe based on reports of 8,252 people who have side effects when taking Robaxin from the FDA, and is updated regularly.

What is Robaxin?

Robaxin has active ingredients of methocarbamol. It is often used in muscle spasms. eHealthMe is studying from 9,109 Robaxin users. Check the latest studies of Robaxin.

What is Bundle branch block right?

Bundle branch block right (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the right ventricle) is found to be associated with 755 drugs and 895 conditions by eHealthMe. Check the latest studies of Bundle branch block right.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

8,252 people reported to have side effects when taking Robaxin.
Among them, 12 people (0.15%) have Bundle branch block right.

Could Robaxin cause Bundle branch block right?

Among these 12 people:

What is the gender of people who have Bundle branch block right when taking Robaxin? *

female: 66.67 %
male: 33.33 %

What is the age of people who have Bundle branch block right when taking Robaxin? *

What are other drugs people take besides Robaxin? *

What are other side effects people have besides Bundle branch block right? *

Pain: 12 people, 100.00%
Stress And Anxiety: 11 people, 91.67%
Haematuria (presence of blood in urine): 10 people, 83.33%
Osteonecrosis Of Jaw (death of bone of jaw): 10 people, 83.33%
Anaemia (lack of blood): 8 people, 66.67%
General Physical Health Deterioration (weak health status): 7 people, 58.33%
Pain In Jaw: 7 people, 58.33%
Osteomyelitis (infection of bone): 7 people, 58.33%
Osteolysis (dissolution of bone): 7 people, 58.33%
Micturition Urgency (urgency to pass the urine): 6 people, 50.00%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 4 people, 33.33%
Bone Disorder: 4 people, 33.33%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Robaxin and have Bundle branch block right?

- Check whether Bundle branch block right is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Robaxin:

Robaxin (9,109 reports)

Browse all side effects of Robaxin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bundle branch block right:

Bundle branch block right (755 drugs)

Browse all the conditions that are associated with Bundle branch block right:

Bundle branch block right (895 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on methocarbamol (the active ingredients of Robaxin) and Robaxin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.